Trial of Iseganan in Prevention of Ventilator-Associated Pneumonia
Status:
Terminated
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
This is a multinational, double-blind, placebo-controlled trial designed to assess whether
iseganan, applied topically to the oral cavity, can prevent ventilator-associated pneumonia
among patients who are intubated and mechanically ventilated and survive for up to 14 days.